Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Schott

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|November 19, 2004
Pathological substrate for regional distribution of increased atrophy rates in progressive supranuclear palsyD C Paviour, J M Schott, J M Stevens, et al.
Neuroimage|December 1, 2021
Not all voxels are created equal: Reducing estimation bias in regional NODDI metrics using tissue-weighted meansC S Parker, T Veale, M Bocchetta, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 21, 2013
A practical approach to diagnosing adult onset leukodystrophiesR M Ahmed, E Murphy, I Davagnanam, et al.
Molecular Psychiatry|February 20, 2013
CSF biomarkers for Alzheimer's pathology and the effect size of APOE ɛ4U Andreasson, R Lautner, J M Schott, et al.
Brain : a Journal of Neurology|May 20, 2005
Brain biopsy in dementiaJ D Warren, J M Schott, N C Fox, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 16, 2015
A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromesN K Magdalinou, R W Paterson, J M Schott, et al.
Translational Psychiatry|November 16, 2016
A targeted proteomic multiplex CSF assay identifies increased malate dehydrogenase and other neurodegenerative biomarkers in individuals with Alzheimer's disease pathologyR W Paterson, W E Heywood, A J Heslegrave, et al.
European Journal of Neurology|March 27, 2015
EFNS-ENS/EAN Guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer's diseaseR Schmidt, E Hofer, F H Bouwman, et al.
Journal of Neurology|December 10, 2014
Oculoleptomeningeal Amyloidosis associated with transthyretin Leu12Pro in an African patientP McColgan, S Viegas, S Gandhi, et al.
Journal of Internal Medicine|May 22, 2021
Transitioning from cerebrospinal fluid to blood tests to facilitate diagnosis and disease monitoring in Alzheimer's diseaseD O T Alawode, A J Heslegrave, N J Ashton, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Journal of Neurology, Neurosurgery, and Psychiatry|November 19, 2004
Pathological substrate for regional distribution of increased atrophy rates in progressive supranuclear palsyD C Paviour, J M Schott, J M Stevens, et al.
Neuroimage|December 1, 2021
Not all voxels are created equal: Reducing estimation bias in regional NODDI metrics using tissue-weighted meansC S Parker, T Veale, M Bocchetta, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 21, 2013
A practical approach to diagnosing adult onset leukodystrophiesR M Ahmed, E Murphy, I Davagnanam, et al.
Molecular Psychiatry|February 20, 2013
CSF biomarkers for Alzheimer's pathology and the effect size of APOE ɛ4U Andreasson, R Lautner, J M Schott, et al.
Brain : a Journal of Neurology|May 20, 2005
Brain biopsy in dementiaJ D Warren, J M Schott, N C Fox, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 16, 2015
A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromesN K Magdalinou, R W Paterson, J M Schott, et al.
Translational Psychiatry|November 16, 2016
A targeted proteomic multiplex CSF assay identifies increased malate dehydrogenase and other neurodegenerative biomarkers in individuals with Alzheimer's disease pathologyR W Paterson, W E Heywood, A J Heslegrave, et al.
European Journal of Neurology|March 27, 2015
EFNS-ENS/EAN Guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer's diseaseR Schmidt, E Hofer, F H Bouwman, et al.
Journal of Neurology|December 10, 2014
Oculoleptomeningeal Amyloidosis associated with transthyretin Leu12Pro in an African patientP McColgan, S Viegas, S Gandhi, et al.
Journal of Internal Medicine|May 22, 2021
Transitioning from cerebrospinal fluid to blood tests to facilitate diagnosis and disease monitoring in Alzheimer's diseaseD O T Alawode, A J Heslegrave, N J Ashton, et al.
Pageof 5